Delivery Order SPE2DB24D1021-SPE2DB25FESVU

Award Date 12/23/24
Potential Completion Date 12/24/24
Potential Value $14K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
  • SPE2DB24D1021
    Indefinite Delivery Contract
  • SPE2DB24D1021-SPE2DB25FESVU
    Delivery Order

This federal contract award to AmerisourceBergen Drug Corp is for the delivery of insulin glargine-yfgn U100 pens. The $13,788.60 firm fixed-price delivery order was issued by the Defense Logistics Agency (DLA), a defense agency that provides medical supplies and pharmaceuticals to the U.S. military and other federal healthcare programs. The contract has an ultimate completion date of December 24, 2024 and was awarded on December 23, 2024. There is no set-aside designation indicated for this contract. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical that serves as a primary vehicle for providing a wide range of pharmaceutical products and medical supplies to support military healthcare programs globally.

Generated 3/24/25, 9:42 AM